DMN:FRA
Diamyd Medical AB
€0.070
0.00%
(0.00) 1D
Sep 30, 8:04:53 AM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DMN...
Mkt. cap
156.03M
Avg. vol.
17.00
Volume
0.00
52-wk high
€1.80
52-wk low
€0.05
No. of employees
44
Mkt. cap
156.03M
Avg. vol.
17.00
Volume
0.00
52-wk high
€1.80
52-wk low
€0.05
No. of employees
44
News stories
From web sources and news partners
MarketBeat
·
14 minutes ago
PLBY Group (NASDAQ:PLBY) Stock Price Down 0.5% - Time to Sell?
Benzinga
·
19 minutes ago
Stock Market: Will S&P 500 Open Up or Down Today?
Simply Wall Street
·
1 hour ago
Learn Why The Bull Case For Amplitude (AMPL) Could Change Following Earnings Beat
Profile
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for type-1 diabetes. The company's investigational drug retogatein is based on a recombinant form of GAD₆₅, one of two human glutamate decarboxylase gene products.
The company is headquartered in Stockholm, and maintains a "biomanufacturing" facility in Umeå which utilizes bacuolavirus-mediated protein expression. Wikipedia
About Diamyd Medical AB